Quantcast

Tag Archives: pharmaceutical

Tasly to launch headquarters in Rockville

Tasly Pharmaceuticals Inc. will hold a ribbon-cutting ceremony on Wednesday at its corporate offices in Rockville to mark the official launch of the North American headquarters of Tasly Holding Group, a global technology company established in China 20 years ago. ...

Read More »

Alba’s celiac therapy seen as promising

Alba Therapeutics Corp., of Baltimore, a developer of drugs to treat autoimmune and inflammatory diseases, said it has seen positive results from a Phase IIb clinical trial of a new drug, larazotide acetate, to treat celiac disease.

Read More »

Baltimore biotech Gliknik, Pfizer sign accord

Gliknik Inc., of Baltimore, a biotech that develops novel molecular treatments for autoimmune/inflammatory diseases and cancer, said it has entered into an exclusive worldwide licensing agreement with drug-making giant Pfizer Inc. for its pharmaceutical candidate, GL-2045, a potential treatment for a variety of autoimmune diseases.

Read More »

Tough pill to swallow

News: The U.S. Supreme Court ruled that pharmaceutical sales representatives aren’t entitled to overtime pay for the extra hours they put in outside the normal business day. View: This decision may make the sales reps feel stressed out. Maybe they ...

Read More »

Maryland mergers and acquisitions surge in 1Q

Bucking a national trend, Maryland mergers and acquisitions rose almost 25 percent in the first quarter of 2012 compared with the last quarter of 2011, with the increase largely driven by the biotechnology, pharmaceutical and medical sector. According to data ...

Read More »

MedImmune, Merck to share Frederick manufacturing space

FREDERICK — MedImmune says it will share its manufacturing space in Frederick with pharmaceutical giant Merck & Co. MedImmune said Wednesday the companies have reached a 15-year deal allowing Merck to use its 385,000-square-foot plant for bulk product manufacturing. MedImmune ...

Read More »

EntreMed narrows second-quarter loss

EntreMed Inc. of Rockville, a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, said it narrowed its loss for the second quarter. EntreMed reported a net loss of $1.7 million, or 17 cents per share, for this year’s ...

Read More »

Ex-CEO of Lux Biosciences named COO at Micromet

BETHESDA — Cancer drug developer Micromet Inc. on Tuesday named Ulrich Grau, a biopharmaceutical industry veteran, as its executive vice president and chief operating officer, effective immediately. Grau has more than 30 years of experience in operations and research and ...

Read More »